Loading company…
Tmunity Therapeutics is a Philadelphia biotech developing T cell and gene therapies for cancer and autoimmune diseases.
Founded in 2015 and headquartered in Philadelphia, US, Tmunity Therapeutics Inc. develops cell and gene therapies using T cell engineering platforms, aimed at cancers and autoimmune diseases. Its founders include Arie Belldegrun and Bruce Levine. In December 2022, the company raised USD 75.00 mn in a Series B round led by Andreessen Horowitz, and Kite Pharma, Inc. acquired it in the same month.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in